Previously, image interpretation in radiology relied heavily on manual methods. However, manual classification of brain tumor medical images is time-consuming and labor-intensive. Even with shallow convolutional neural network models, the accuracy is not ideal. To improve the efficiency and accuracy of brain tumor image classification, this paper proposes a brain tumor classification model based on an improved ResNet34 network. This model uses the ResNet34 residual network as the backbone network and incorporates multi-scale feature extraction. It uses a multi-scale input module as the first layer of the ResNet34 network and an Inception v2 module as the residual downsampling layer. Furthermore, a channel attention mechanism module assigns different weights to different channels of the image from a channel domain perspective, obtaining more important feature information. The results after a five-fold crossover experiment show that the average classification accuracy of the improved network model is approximately 98.8%, which is not only 1% higher than ResNet34, but also only 80% of the number of parameters of the original model. Therefore, the improved network model not only improves accuracy but also reduces clutter, achieving a classification effect with fewer parameters and higher accuracy.

Brain tumor detection from MRI scans plays a crucial role in early diagnosis and treatment planning. Deep convolutional neural networks (CNNs) have demonstrated strong performance in medical imaging tasks, particularly when pretrained on large datasets. However, it remains unclear which type of pretrained model performs better when only a small dataset is available: those trained on domain-specific medical data or those pretrained on large general datasets. In this study, we systematically evaluate three pretrained CNN architectures for brain tumor classification: RadImageNet DenseNet121 with medical-domain pretraining, EfficientNetV2S, and ConvNeXt-Tiny, which are modern general-purpose CNNs. All models were trained and fine-tuned under identical conditions using a limited-size brain MRI dataset to ensure a fair comparison. Our results reveal that ConvNeXt-Tiny achieved the highest accuracy, followed by EfficientNetV2S, while RadImageNet DenseNet121, despite being pretrained on domain-specific medical data, exhibited poor generalization with lower accuracy and higher loss. These findings suggest that domain-specific pretraining may not generalize well under small-data conditions. In contrast, modern, deeper general-purpose CNNs pretrained on large-scale datasets can offer superior transfer learning performance in specialized medical imaging tasks.

Accurate brain tumor classification is critical for intra-operative decision making in neuro-oncological surgery. However, existing approaches are restricted to a fixed set of predefined classes and are therefore unable to capture patterns of tumor types not available during training. Unsupervised learning can extract general-purpose features, but it lacks the ability to incorporate prior knowledge from labelled data, and semi-supervised methods often assume that all potential classes are represented in the labelled data. Generalized Category Discovery (GCD) aims to bridge this gap by categorizing both known and unknown classes within unlabelled data. To reflect the hierarchical structure of brain tumor taxonomies, in this work, we introduce Hierarchical Generalized Category Discovery for Brain Tumor Classification (HGCD-BT), a novel approach that integrates hierarchical clustering with contrastive learning. Our method extends contrastive learning based GCD by incorporating a novel semi-supervised hierarchical clustering loss. We evaluate HGCD-BT on OpenSRH, a dataset of stimulated Raman histology brain tumor images, achieving a +28% improvement in accuracy over state-of-the-art GCD methods for patch-level classification, particularly in identifying previously unseen tumor categories. Furthermore, we demonstrate the generalizability of HGCD-BT on slide-level classification of hematoxylin and eosin stained whole-slide images from the Digital Brain Tumor Atlas, confirming its utility across imaging modalities.

The early and accurate classification of brain tumors is crucial for guiding effective treatment strategies and improving patient outcomes. This study presents BrainFusion, a significant advancement in brain tumor analysis using magnetic resonance imaging (MRI) by combining fine-tuned convolutional neural networks (CNNs) for tumor classification--including VGG16, ResNet50, and Xception--with YOLOv8 for precise tumor localization with bounding boxes. Leveraging the Brain Tumor MRI Dataset, our experiments reveal that the fine-tuned VGG16 model achieves test accuracy of 99.86%, substantially exceeding previous benchmarks. Beyond setting a new accuracy standard, the integration of bounding-box localization and explainable AI techniques further enhances both the clinical interpretability and trustworthiness of the system's outputs. Overall, this approach underscores the transformative potential of deep learning in delivering faster, more reliable diagnoses, ultimately contributing to improved patient care and survival rates.

Brain tumors are serious health problems that require early diagnosis due to their high mortality rates. Diagnosing tumors by examining Magnetic Resonance Imaging (MRI) images is a process that requires expertise and is prone to error. Therefore, the need for automated diagnosis systems is increasing day by day. In this context, a robust and explainable Deep Learning (DL) model for the classification of brain tumors is proposed. In this study, a publicly available Figshare dataset containing 3,064 T1-weighted contrast-enhanced brain MRI images of three tumor types was used. First, the classification performance of nine well-known CNN architectures was evaluated to determine the most effective backbone. Among these, EfficientNetV2 demonstrated the best performance and was selected as the backbone for further development. Subsequently, an attention-based MLP-Mixer architecture was integrated into EfficientNetV2 to enhance its classification capability. The performance of the final model was comprehensively compared with basic CNNs and the methods in the literature. Additionally, Grad-CAM visualization was used to interpret and validate the decision-making process of the proposed model. The proposed model's performance was evaluated using the five-fold cross-validation method. The proposed model demonstrated superior performance with 99.50% accuracy, 99.47% precision, 99.52% recall and 99.49% F1 score. The results obtained show that the model outperforms the studies in the literature. Moreover, Grad-CAM visualizations demonstrate that the model effectively focuses on relevant regions of MRI images, thus improving interpretability and clinical reliability. A robust deep learning model for clinical decision support systems has been obtained by combining EfficientNetV2 and attention-based MLP-Mixer, providing high accuracy and interpretability in brain tumor classification.

DNA microarray technology enables the simultaneous measurement of expression levels of thousands of genes, thereby facilitating the understanding of the molecular mechanisms underlying complex diseases such as brain tumors and the identification of diagnostic genetic signatures. To derive meaningful biological insights from the high-dimensional and complex gene features obtained through this technology and to analyze gene properties in detail, classical AI-based approaches such as machine learning and deep learning are widely employed. However, these methods face various limitations in managing high-dimensional vector spaces and modeling the intricate relationships among genes. In particular, challenges such as hyperparameter tuning, computational costs, and high processing power requirements can hinder their efficiency. To overcome these limitations, quantum computing and quantum AI approaches are gaining increasing attention. Leveraging quantum properties such as superposition and entanglement, quantum methods enable more efficient parallel processing of high-dimensional data and offer faster and more effective solutions to problems that are computationally demanding for classical methods. In this study, a novel model called "Deep VQC" is proposed, based on the Variational Quantum Classifier approach. Developed using microarray data containing 54,676 gene features, the model successfully classified four different types of brain tumors-ependymoma, glioblastoma, medulloblastoma, and pilocytic astrocytoma-alongside healthy samples with high accuracy. Furthermore, compared to classical ML algorithms, our model demonstrated either superior or comparable classification performance. These results highlight the potential of quantum AI methods as an effective and promising approach for the analysis and classification of complex structures such as brain tumors based on gene expression features.

Brain tumors show significant health challenges due to their potential to cause critical neurological functions. Early and accurate diagnosis is crucial for effective treatment. In this research, we propose ResLink, a novel deep learning architecture for brain tumor classification using CT scan images. ResLink integrates novel area attention mechanisms with residual connections to enhance feature learning and spatial understanding for spatially rich image classification tasks. The model employs a multi-stage convolutional pipeline, incorporating dropout, regularization, and downsampling, followed by a final attention-based refinement for classification. Trained on a balanced dataset, ResLink achieves a high accuracy of 95% and demonstrates strong generalizability. This research demonstrates the potential of ResLink in improving brain tumor classification, offering a robust and efficient technique for medical imaging applications.

The use of Convolutional Neural Networks (CNNs) has greatly improved the interpretation of medical images. However, conventional CNNs typically demand extensive computational resources and large training datasets. To address these limitations, this study applied transfer learning to achieve strong classification performance using fewer training samples. Specifically, the study compared EfficientNetV2 with its predecessor, EfficientNet, and with ResNet50 in classifying brain tumors into three types: glioma, meningioma, and pituitary tumors. Results showed that EfficientNetV2 delivered superior performance compared to the other models. However, this improvement came at the cost of increased training time, likely due to the model's greater complexity.

The framework is designed to improve performance in the analysis of combined as well as single anatomical perspectives for MRI disease diagnosis. It specifically addresses the performance degradation observed in state-of-the-art (SOTA) models, particularly when processing axial, coronal, and sagittal anatomical planes. The paper introduces the FOLC-Net framework, which incorporates a novel federated-optimized lightweight architecture with approximately 1.217 million parameters and a storage requirement of only 0.9 MB. FOLC-Net integrates Manta-ray foraging optimization (MRFO) mechanisms for efficient model structure generation, global model cloning for scalable training, and ConvNeXt for enhanced client adaptability. The model was evaluated on combined multi-view data as well as individual views, such as axial, coronal, and sagittal, to assess its robustness in various medical imaging scenarios. Moreover, FOLC-Net tests a ShallowFed model on different data to evaluate its ability to generalize beyond the training dataset. The results show that FOLC-Net outperforms existing models, particularly in the challenging sagittal view. For instance, FOLC-Net achieved an accuracy of 92.44% on the sagittal view, significantly higher than the 88.37% accuracy of study method (DL + Residual Learning) and 88.95% of DL models. Additionally, FOLC-Net demonstrated improved accuracy across all individual views, providing a more reliable and robust solution for medical image analysis in decentralized environments. FOLC-Net addresses the limitations of existing SOTA models by providing a framework that ensures better adaptability to individual views while maintaining strong performance in multi-view settings. The incorporation of MRFO, global model cloning, and ConvNeXt ensures that FOLC-Net performs better in real-world medical applications.

We propose HQCM-EBTC, a hybrid quantum-classical model for automated brain tumor classification using MRI images. Trained on a dataset of 7,576 scans covering normal, meningioma, glioma, and pituitary classes, HQCM-EBTC integrates a 5-qubit, depth-2 quantum layer with 5 parallel circuits, optimized via AdamW and a composite loss blending cross-entropy and attention consistency. HQCM-EBTC achieves 96.48% accuracy, substantially outperforming the classical baseline (86.72%). It delivers higher precision and F1-scores, especially for glioma detection. t-SNE projections reveal enhanced feature separability in quantum space, and confusion matrices show lower misclassification. Attention map analysis (Jaccard Index) confirms more accurate and focused tumor localization at high-confidence thresholds. These results highlight the promise of quantum-enhanced models in medical imaging, advancing both diagnostic accuracy and interpretability for clinical brain tumor assessment.